Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CGM097
i
Other names:
CGM097, NVP-CGM097
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Novartis
Drug class:
MDM2 inhibitor
Related drugs:
‹
KRT-232 (18)
RAIN-32 (13)
RG7388 (10)
APG-115 (9)
ALRN-6924 (3)
HDM201 (3)
MK-8242 (2)
Nutlin-3 (1)
ASTX295 (0)
DS-5272 (0)
MI-773 (0)
RG7112 (0)
RG7775 (0)
JNJ-26854165 (0)
KRT-232 (18)
RAIN-32 (13)
RG7388 (10)
APG-115 (9)
ALRN-6924 (3)
HDM201 (3)
MK-8242 (2)
Nutlin-3 (1)
ASTX295 (0)
DS-5272 (0)
MI-773 (0)
RG7112 (0)
RG7775 (0)
JNJ-26854165 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
ER positive
Estrogen Receptor Positive Breast Cancer
ER positive
Estrogen Receptor Positive Breast Cancer
palbociclib + CGM097
Sensitive: D – Preclinical
palbociclib + CGM097
Sensitive
:
D
palbociclib + CGM097
Sensitive: D – Preclinical
palbociclib + CGM097
Sensitive
:
D
ER positive
Estrogen Receptor Positive Breast Cancer
ER positive
Estrogen Receptor Positive Breast Cancer
CGM097
Sensitive: D – Preclinical
CGM097
Sensitive
:
D
CGM097
Sensitive: D – Preclinical
CGM097
Sensitive
:
D
GNAQ mutation
Uveal Melanoma
GNAQ mutation
Uveal Melanoma
AEB071 + CGM097
Sensitive: D – Preclinical
AEB071 + CGM097
Sensitive
:
D
AEB071 + CGM097
Sensitive: D – Preclinical
AEB071 + CGM097
Sensitive
:
D
GNA11 mutation
Uveal Melanoma
GNA11 mutation
Uveal Melanoma
AEB071 + CGM097
Sensitive: D – Preclinical
AEB071 + CGM097
Sensitive
:
D
AEB071 + CGM097
Sensitive: D – Preclinical
AEB071 + CGM097
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login